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Abstract 1 
Impaired endothelial vasodilatation may contribute to the exaggerated blood pressure (BP) 2 
responses to exercise in individuals who are overweight/obese. This study investigated 3 
whether consumption of cocoa flavanols, which improve endothelium-dependent flow-4 
mediated dilatation (FMD), can modify BP responsiveness to exercise. 21 volunteers (8 5 
females, 13 males, 54.9 (2.2 ) years, BMI: 31.6 (0.8) kg/m2, systolic BP 134 (2) mmHg, 6 
diastolic BP 87 (2) mmHg) were randomised to consume single serves of either a high 7 
flavanol (HF, 701mg) or a low flavanol (LF, 22mg) cocoa beverage in a double-blind cross-8 
over design with 3-7 day washout between treatments. Two hours after cocoa consumption 9 
FMD was measured, followed by continuous beat to beat assessment (Finapres) of BP prior 10 
to and during 10 min of cycling at 75% of age-predicted maximum heart rate. Averaged data 11 
from 2 assessments on each type of beverage were compared by analysis of covariance using 12 
pre-exercise BP as the covariate. Pre-exercise BP was similar after taking LF and HF (153 13 
(3)/88 (3) vs 153  (4)/87 (2) mmHg respectively, P >0.05). However, the BP response to 14 
exercise (area under BP curve) was attenuated by HF compared with LF. BP increases were 15 
68% lower for diastolic BP (P=0.03) and 14% lower for mean BP (P=0.05). FMD 16 
measurements were higher after HF than LF (6.1 (0.6)% vs 3.4 (0.5)%, P<0.001). By 17 
facilitating vasodilation and attenuating exercise induced increases in BP, cocoa flavanols 18 
may decrease cardiovascular risk and enhance the cardiovascular benefits of moderate 19 
intensity exercise in at-risk individuals.  20 
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INTRODUCTION 21 
Impaired endothelial vasodilator function is an important contributor to the development of 22 
cardiovascular disease 1, but it is not yet clear how it impacts on other biomarkers of 23 
cardiovascular health.  24 
It has been well-established that obesity and hypertension are associated with impaired nitric 25 
oxide (NO) dependent vasodilatation 2-3. Reduced availability of NO significantly impairs the 26 
degree of blood vessel dilatation in response to cardiovascular stressors, such as exercise 4.  27 
The typical cardiovascular response to aerobic exercise is an increase in heart rate (HR) and 28 
cardiac output which elicits an increase in systolic BP (SBP). Diastolic BP (DBP) either 29 
remains unchanged or decreases slightly due to vasodilatation in the exercising muscles, 30 
resulting in increased pulse pressure. Impaired endothelial function (as measured by flow 31 
mediated dilatation (FMD)) has been associated with exaggerated BP responses to exercise 5 32 
which have been linked to an increased risk of developing future hypertension 6-8. This 33 
therefore suggests that individuals with impaired vasodilatation such as those who are obese 34 
or have elevated BP may have exaggerated BP responses to exercise, thus making them 35 
predisposed to acute risk during exercise 9. 36 
Previous attempts to evaluate this emerging risk factor have been limited by the techniques 37 
available to measure BP responsiveness to exercise. Most studies have used graded exercise 38 
tests with single BP measurements taken at the end of each workload. The introduction of 39 
non-invasive techniques for continuous beat-to-beat monitoring of BP enables cardiovascular 40 
responses to be measured during rather than after exercise, thus offering a more physiological 41 
representation of the effects of impaired dilatation on cardiovascular function, compared with 42 
the commonly used but somewhat artificial FMD response to passive hyperaemia.  43 
Recent studies have shown that the short-term intake of cocoa polyphenols can lower blood 44 
pressure (BP) and improve endothelium-dependent vasodilatation 10-13. The mechanism by 45 
which cocoa exerts its antihypertensive effect is yet to be determined but the effect may be 46 
mediated through enhanced endothelial function 14, with the cocoa polyphenols increasing the 47 
activity of nitric oxide synthase in endothelial cells 15-16, which can lead to enhanced 48 
endothelium-dependent vasodilatation 17-18 and improved blood pressure. . Thus, there may 49 
also be potential for cocoa flavanols to attenuate the BP increases in response to physiological 50 
stressors such as exercise. 51 
The aim of this study was to see whether improvements in FMD seen in overweight 52 
individuals following consumption of flavanol-rich cocoa 11 can also improve their 53 
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exaggerated BP responses to aerobic exercise (measured by decreased area under the curve 54 
for SBP, DBP and mean arterial pressure (MAP) during submaximal exercise). 55 
METHODS 56 
A randomised, double-blind, cross-over trial to test acute effects of cocoa flavanols on BP 57 
responsiveness to exercise was conducted. This study was conducted according to the 58 
guidelines laid down in the Declaration of Helsinki and all procedures involving human 59 
subjects/patients were approved by the University of South Australia Human Research Ethics 60 
Committee and conducted at the Nutritional Physiology Research Centre. Written informed 61 
consent was obtained from all subjects. 62 
Men and post-menopausal women who were overweight or obese (BMI> 25 kg/m2) but 63 
otherwise healthy were recruited. Volunteers had no history of cardiovascular disease, 64 
diabetes or renal disease, were not taking diabetic or BP lowering medication and had seated 65 
clinic SBP ≤160 mmHg and DBP ≤100 mmHg. Participants were not intolerant to alkaloids 66 
(caffeine, theobromine) or dairy, currently smoking or using nicotine replacement therapy. 67 
Volunteers visited the Centre at the same time of day on 5 occasions. At the first (screening) 68 
visit, they undertook an exercise test on a cycle ergometer (Monark, Model 828, Vansbro, 69 
Sweden) to determine the required workload for subsequent exercise tests. They were 70 
required to ride the cycle ergometer for 10 minutes at a workload eliciting a HR equivalent to 71 
75% of their age-predicted maximum (208–(0.7 x age [yr]))*0.75) 19 and their ECG was 72 
monitored by a medical practitioner to confirm their suitability to continue exercising.  73 
Volunteers were then provided with a dairy-based cocoa beverage powder which was either 74 
high (HF) or low (LF) in cocoa flavanols (refers herein to epicatechin and catechin as well as 75 
their procyanidin oligomers up to and including decamers). Reconstituted in 200 ml water, the 76 
cocoa beverages provided a total of either 701 mg of cocoa flavanols (HF: 139 mg 77 
epicatechin, 39 mg catechin and 523 mg procyanidins) or 22 mg of cocoa flavanols (LF: 0 mg 78 
epicatechin, 9 mg catechin and 13 mg procyanidins). The LF and HF cocoa drinks were 79 
matched in appearance, macronutrient, micronutrient, and alkaloid (caffeine and theobromine) 80 
content, with the only exception being the cocoa flavanol content, see Table 1 for nutrient 81 
composition of products. The sachets were labelled with a three-digit numerical code, 82 
blinding both volunteers and investigators to their identity throughout the study. Empty 83 
sachets were collected to monitor compliance. 84 
The sequence of events on each of the four visits was as follows: 85 
1. Volunteers fasted from food and drink (except water) for  4 hours 86 
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2. Supplement was consumed. 87 
3. FMD was conducted 2 hours after supplementation. Previous research has 88 
demonstrated a peak effect of cocoa flavanols on FMD at 2 hours after consumption 16 89 
which returns to baseline 6 hours after consumption 20-21. The assessment of FMD in 90 
the brachial artery was performed using 2-dimensional B-mode ultrasound (LOGIQ 5; 91 
GE Medical Systems, Waukesha, WI). Optimal imaging of the artery was achieved 92 
using the method of Raitakari and Celermajer 22. A sphygmomanometer cuff was 93 
placed around upper forearm in line with the cubital fossa (ie, distal to the scanned 94 
part of the artery) and inflated to supra-systolic pressure (200 mmHg) for 5 min. 95 
Images of the artery were taken before cuff inflation, 10 s before cuff release, 10 s 96 
after cuff release, and then every 30 s for an additional 3 min to assess the EVF 97 
response to reactive hyperaemia. 98 
4. Clinic BP was measured by oscillometry (SpaceLabs Model 90217, SpaceLabs 99 
Medical, Florida, USA) while subjects were seated on the cycle ergometer prior to the 100 
commencement of exercise. 101 
During the subsequent exercise test BP and HR were measured continuously using a 102 
Finapres BP monitor (Ohmeda Inc., Englewood, Colorado) with the hand steadied 103 
in a support which was maintained at a constant height for all occasions. The test 104 
commenced with a 5 minute pre-exercise period of sitting on the cycle ergometer 105 
before a 10 min bout of exercise at a workload eliciting 75% of the subject’s age 106 
predicted maximum HR 19. 107 
This protocol was repeated twice with each cocoa drink (LF or HF) in random order at with a 108 
3-7 day washout between visits and the repeat measures for each supplement were averaged.  109 
Diet and lifestyle requirements during the study 110 
Volunteers were asked to consume a low-flavanol diet during the study period, specifically 111 
participants were asked to limit their intake of fruit or fruit containing juices, apples, tea 112 
(green, black, herbal, chai, brewed or bottled), coffee or caffeinated beverages, 113 
cocoa/chocolate or cocoa/chocolate containing products, honey, soybeans, and soy containing 114 
products, nuts/nut products containing nut skins, red wine. Participants were provided with 115 
written and verbal reminders to ensure compliance with this request. 116 
Data analysis 117 
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Using the Finapres™ BP monitor, data was obtained for every heart beat during the 15 minute 118 
protocol, then averaged in 30 second blocks. The final 30 seconds of the seated BP and HR 119 
assessment was taken to be the pre-exercise HR and BP.  120 
The changes in BP and HR during exercise were calculated by subtracting the average of each 121 
30 second block during exercise from this pre-exercise average. These 30 second averages 122 
were used to calculate the area under the curve (AUC) for the change in BP from pre-exercise 123 
values to give an integrated BP response to exercise. 124 
Brachial artery diameter was assessed manually at each time point using the integrated digital 125 
callipers by a single observer who was blinded to the treatment group. FMD was reported as 126 
the maximum % change from baseline in blood vessel diameter following the cuff occlusion, 127 
as described previously 11. 128 
Two-way analysis of covariance (ANCOVA) was used to compare the effects of cocoa 129 
supplementation on both FMD and the BP response to exercise, with baseline arterial 130 
diameter and pre-exercise BP used as covariates using STATISTICA v5.1 (StatSoft Inc, 131 
Tulsa, OK, USA). Relationships between FMD and the BP responses to exercise were 132 
determined by linear regression analysis. P < 0.05 was taken to indicate statistical 133 
significance. All data are presented as mean ± standard error unless otherwise stated. 134 
RESULTS 135 
A total of 21 volunteers (thirteen men and eightwomen, age 55 ± 2.2 years, height 1.7 ± 0.02 136 
m, weight 94.1 ± 3.5 kg, BMI 31.6 ± 0.8 kg/m2, SBP 134 ± 2 mmHg, DBP 87 ± 2 mmHg) 137 
completed the trial. Using an existing database of potential volunteers, individuals identified 138 
as having a BMI> 25 kg/m2 were invited to return to perform this trial. Of the 25 people who 139 
were contacted, 21 volunteers agreed to participate. There were no withdrawals from this 140 
study. 141 
Flow Mediated Dilatation 142 
Fig 1 demonstrates the FMD response to HF and LF cocoa. Two hours after consumption, the 143 
HF cocoa beverage resulted in a significantly greater FMD response than the LF cocoa 144 
beverage, p<0.001. 145 
Pre-exercise BP 146 
Pre-exercise BP and HR were measured by Finapres finger plethysmography whilst on cycle 147 
ergometer. Data were averaged from the final 30 seconds of the pre-exercise period prior to 148 
the commencement of exercise. These readings are likely to differ from the clinic BP readings 149 
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due to hydrostatic differences between the relative heights of the finger cuff and the brachial 150 
artery. There were no significant differences between HF and LF cocoa beverage 151 
consumption on the pre-exercise BP (HF: SBP/DBP 153 ± 3/88 ± 3 mmHg, HR 79 ± 2 bpm; 152 
LF: SBP/DBP 153 ± 4/88 ± 2 mmHg, HR 79 ± 2 bpm). 153 
Responses to exercise. 154 
Both HR and BP increased in response to the cycling exercise. However, there were no 155 
significant differences in the HR response following consumption of the HF or LF cocoa 156 
beverages. On the other hand, the increases in BP were attenuated by HF cocoa consumption 157 
compared with LF cocoa consumption. Fig 2 demonstrates the changes from pre-exercise 158 
values for the BP responses to exercise for each 30 second block over the entire 10 minute 159 
exercise bout. Table 2 shows the integrated responses for BP increases during exercise. After 160 
adjusting for pre-exercise BP, the AUC was reduced 68% for DBP (P=0.03) and 14% for 161 
MAP (P=0.05) following HF cocoa consumption compared to LF cocoa consumption 162 
Relationship between changes in FMD and changes in BP response to exercise. 163 
Comparison of differences between HF and LF in the FMD and BP responses to exercise 164 
revealed no significant relationships between the differences in FMD and the differences in 165 
SBP (r=0.06, P=0.78), DBP (r= 0.42, P=0.06) or MAP (r=0.28, P=0.22), although the 166 
relationship between FMD and DBP approached statistical significance. 167 
DISCUSSION 168 
Results of the present study confirm that consuming a single dose of HF cocoa results in a 169 
significant improvement in FMD after two hours.  Moreover, they demonstrate that acute 170 
ingestion of HF cocoa can also attenuate the BP response to exercise.  171 
Conditions such as obesity, diabetes and hypertension are known to impair vasodilatation 2-3 172 
and may potentially cause an increase in DBP during exercise. In the present study, there was 173 
indeed an exercise-induced increase in DBP (Fig 2), but the increase was attenuated by 174 
supplementation with HF cocoa. 175 
This reduction in DBP response tended to correlate with the increase in FMD following HF 176 
consumption (P = 0.06), suggesting that this benefit may be due to improved endothelium 177 
dependant dilatation. While some published studies have also found a relationship between 178 
exercise BP and FMD 5, 23, others have not 24. Green et al 25 found no relationship between 179 
improvements in conduit vessel function (as measured by FMD) or resistance vessel function 180 
(strain gauge plethysmography of total forearm blood flow) and improvements in exercise-181 
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induced vasodilatation following exercise training. The role of NO as a mediator of exercise-182 
induced vasodilatation is controversial. A recent review by Tzemos et al. 4 concluded that 183 
there may be a role for NO in mediating exercise-induced vasodilatation but, of the studies 184 
that have examined the role of NO in exercise-induced vasodilatation 5, 23-24, most have 185 
reported that, while NO does contribute 5, 23, there are also many other factors which mediate 186 
the vasodilatory response to exercise. Although the relationship between improvement in 187 
FMD and attenuation of the blood pressure response to exercise was not significant, it is 188 
likely that this study was not sufficiently powered to confirm this relationship. 189 
The finding of an improvement in FMD following consumption of HF in the current study is 190 
consistent with a growing body of evidence indicating beneficial effects of cocoa flavanols for 191 
endothelial function 10-11, 13, 17-18, 21. The mechanism by which cocoa flavanols influence 192 
vasodilatation is yet to be clearly identified although it appears to be via an increase in the 193 
bioavailability of NO due to increased NO production 13, 26-27.  Previous research has shown 194 
that after consumption of a similar cocoa product, plasma levels of flavanols peak at 195 
approximately 2 hours post-consumption. In addition pure epicatechin consumption closely 196 
mimicked the effect of the cocoa beverage, suggesting that epicatechin may be the flavanol 197 
responsible for the improvements in vascular function 28, however this study was a proof of 198 
concept study with N=3. Therefore further research is required to fully elucidate which 199 
flavanols in cocoa can provide the observed benefits in vascular function. 200 
It is important to note that the flavanol rich cocoa beverages used in this study may not deliver 201 
the same benefits as dark chocolate consumption. In a study by Hammerstone et al 2000, it 202 
was demonstrated that dark chocolate contains approximately 4.3 mg of flavanols per gram. 203 
To achieve the amount of flavanols seen in this study (701mg) would require the consumption 204 
of 163g of dark chocolate or approximately double that amount of milk chocolate 29. Given 205 
that 163g of dark chocolate provides approximately 3526 kJ and 28g of saturated fat 30 it 206 
would be preferable to deliver cocoa flavanols for health benefits in a beverage form such as 207 
that used in this study which delivered 610 kJ and 0.9g of saturated fat. 208 
In conclusion, the results of the present study provide further support for acute consumption 209 
of cocoa flavanols to improve FMD, and they provide new evidence that cocoa flavanols can 210 
also attenuate the BP responses to exercise.  211 
These findings suggest that the consumption of cocoa flavanols may be able to enhance 212 
muscle blood flow to allow for improved nutrient delivery and removal to exercising muscles 213 
and attenuate the blood pressure responses to exercise, which could allow for safer and more 214 
efficient exercise performance in an at risk population such as that include in this study, thus 215 
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placing less stress on the cardiovascular system during exercise. Furthermore these 216 
improvements in FMD and BP response to exercise add to growing evidence that HF cocoa 217 
consumption may benefit individuals with cardiovascular risk factors. 218 
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Table 1: Nutritional profile for each cocoa dose (2 sachets) of cocoa product. 
 
Flavanols (mg) 22 701 
Weight (g) 39 39 
Energy (kJ) 603 610 
Total fat (g) 1.7 1.7 
Sat fat (g) 0.9 0.9 
Total CHO (g) 20.6 20.6 
Sugars (g) 11.5 11.8 
Protein (g) 11.4 11.4 
Caffeine (mg) 31.1 27.2 
Theobromine (mg) 268.1 307.0 
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Table 2. Area under the curve for the blood pressure responses to exercise between high 
flavanol and low flavanol cocoa (mean and standard error). *= significant decrease in the BP 
response to exercise when analysed with pre-exercise BP as the covariate (p<0.05). 
 
 
 
SBP, systolic blood pressure, DBP, diastolic blood pressure, MAP, mean arterial pressure, 
PP, pulse pressure LF, low flavanol, HF, high flavanol, Δ, difference between high 
flavanol and low flavanol response. 
 
SBP 
(mmHg x sec) 
 DBP 
(mmHg x sec) 
 MAP 
(mmHg x sec) 
 PP 
(mmHg x sec) 
 mean SE  mean SE  mean SE  mean SE 
LF (22 mg) 30155 2021  2359 822  10570 1090  27796 1913 
HF (712 mg) 28850 2234  743 1098  9067 1281  28106 1971 
Δ -1305 1904  -1616 902*  -1503 962*  310 59 
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Figure Captions 
 
Figure 1. %FMD following high and low flavanol cocoa consumption. * = significant 
difference (p<0.05) between HF (white bars) and LF (black bars). 
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Figure 2. BP responses to exercise represented high (white circles) and low flavanol (black 
circles) cocoa consumption as change from pre-exercise values. 
 
